|
Sunshine Biopharma, Inc. (SBFM) Évaluation DCF |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
Sunshine Biopharma, Inc. (SBFM) Bundle
En tant qu'investisseur ou analyste, cette calculatrice DCF (SBFM) est votre ressource incontournable pour une évaluation précise. Chargé de données réelles de Sunshine Biopharma, Inc., vous pouvez facilement ajuster les prévisions et observer les effets en temps réel.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .1 | .2 | 4.3 | 24.1 | 34.9 | 64.9 | 120.9 | 225.1 | 419.1 | 780.3 |
| Revenue Growth, % | 0 | 219.88 | 1802.41 | 454.42 | 44.75 | 86.19 | 86.19 | 86.19 | 86.19 | 86.19 |
| EBITDA | -2.6 | -12.1 | -26.4 | -3.8 | -5.2 | -42.9 | -79.9 | -148.9 | -277.1 | -516.0 |
| EBITDA, % | -3643.64 | -5294.88 | -608.58 | -15.87 | -14.78 | -66.13 | -66.13 | -66.13 | -66.13 | -66.13 |
| Depreciation | .0 | .0 | .0 | .1 | .2 | 3.5 | 6.6 | 12.2 | 22.7 | 42.3 |
| Depreciation, % | 19.7 | 5.58 | 0.57905 | 0.61905 | 0.64095 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 |
| EBIT | -2.6 | -12.1 | -26.5 | -4.0 | -5.4 | -43.1 | -80.3 | -149.4 | -278.2 | -518.0 |
| EBIT, % | -3663.33 | -5300.46 | -609.16 | -16.49 | -15.42 | -66.38 | -66.38 | -66.38 | -66.38 | -66.38 |
| Total Cash | 1.0 | 2.0 | 21.8 | 16.3 | 9.7 | 51.3 | 95.6 | 178.0 | 331.4 | 617.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | 1.9 | 2.6 | 3.9 | 9.3 | 17.4 | 32.3 | 60.2 | 112.0 |
| Account Receivables, % | 2.68 | 3.41 | 44 | 10.59 | 11.09 | 14.36 | 14.36 | 14.36 | 14.36 | 14.36 |
| Inventories | .0 | .1 | 3.3 | 5.7 | 11.3 | 27.5 | 51.1 | 95.2 | 177.2 | 329.9 |
| Inventories, % | 33.29 | 46.25 | 75.71 | 23.8 | 32.34 | 42.28 | 42.28 | 42.28 | 42.28 | 42.28 |
| Accounts Payable | .1 | .0 | 2.8 | 2.6 | 5.5 | 25.7 | 47.9 | 89.1 | 165.9 | 308.9 |
| Accounts Payable, % | 88.04 | 18.8 | 64.5 | 10.73 | 15.89 | 39.59 | 39.59 | 39.59 | 39.59 | 39.59 |
| Capital Expenditure | .0 | .0 | -.3 | -.8 | .0 | -1.6 | -2.9 | -5.4 | -10.0 | -18.7 |
| Capital Expenditure, % | -1.67 | 0 | -7.02 | -3.27 | 0 | -2.39 | -2.39 | -2.39 | -2.39 | -2.39 |
| Tax Rate, % | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 |
| EBITAT | -.8 | -12.4 | -26.7 | -4.4 | -5.1 | -36.9 | -68.7 | -127.9 | -238.1 | -443.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -.8 | -12.5 | -29.3 | -8.3 | -8.8 | -36.4 | -74.5 | -138.8 | -258.4 | -481.2 |
| WACC, % | 3.65 | 5.06 | 5.06 | 5.06 | 4.97 | 4.76 | 4.76 | 4.76 | 4.76 | 4.76 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -819.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -491 | |||||||||
| Terminal Value | -17,794 | |||||||||
| Present Terminal Value | -14,104 | |||||||||
| Enterprise Value | -14,923 | |||||||||
| Net Debt | -9 | |||||||||
| Equity Value | -14,915 | |||||||||
| Diluted Shares Outstanding, MM | 1 | |||||||||
| Equity Value Per Share | -21,253.37 |
What You Will Get
- Pre-Filled Financial Model: Sunshine Biopharma's actual data facilitates accurate DCF valuation.
- Full Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
- Instant Calculations: Real-time updates provide immediate results as you adjust inputs.
- Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
- Customizable and Reusable: Designed for adaptability, allowing multiple uses for comprehensive forecasts.
Key Features
- 🔍 Real-Life SBFM Financials: Pre-filled historical and projected data for Sunshine Biopharma, Inc. (SBFM).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Sunshine Biopharma’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Sunshine Biopharma’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download the Template: Obtain immediate access to the Excel-based SBFM DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, profit margins, and more.
- Instant Calculations: The model automatically recalculates Sunshine Biopharma’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Leverage the results to inform your investment or financial analysis.
Why Choose This Calculator?
- Designed for Experts: A sophisticated tool utilized by researchers, executives, and financial analysts.
- Accurate Data: Sunshine Biopharma’s historical and projected financials are preloaded for precision.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the process.
Who Should Use Sunshine Biopharma, Inc. (SBFM)?
- Biotechnology Students: Explore drug development processes and apply theoretical knowledge with real-world data.
- Researchers: Utilize cutting-edge models and data for innovative studies in pharmaceutical sciences.
- Investors: Evaluate your investment strategies and analyze the potential of Sunshine Biopharma's pipeline.
- Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech companies.
- Healthcare Entrepreneurs: Understand the evaluation methods used for biotech firms like Sunshine Biopharma, Inc. (SBFM).
What the Template Contains
- Pre-Filled DCF Model: Sunshine Biopharma’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Sunshine Biopharma’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.